Results 211 to 220 of about 39,758 (253)

Clopidogrel resistance "Live" � the risk of stent thrombosis should be evaluated before procedures [PDF]

Iuri Marinov, Jan Kvasnicka, Jaroslava Hajkova, null null, Petr Widimsky, Robert Petr, Zuzana Motovska   +6 more
core   +1 more source

Clopidogrel Resistance and Ticagrelor Replacement in Dual Antiplatelet Therapy for Carotid Artery Stenting

Daniela Mazzaccaro, Matteo Giannetta, Marco Ranucci, Paolo Righini, Di Dedda Umberto, Ekaterina Baryshnikova, Valentina Milani, Giovanni Nano   +7 more
openalex   +1 more source

<b>The Multifaceted Nature of Clopidogrel Resistance: Integrating Pharmacodynamic, Pharmacokinetic, and Pharmacogenomic </b>

Andika Yusuf Ramadhan
openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Clopidogrel Resistance

Heart, Lung and Circulation, 2007
Clopidogrel resistance has been used as one of the terms employed in the literature to describe different degrees of ex vivo low platelet inhibition after clopidogrel administration. In addition to the diverse nomenclature, the characterisation of clopidogrel resistance has also been problematic because different authors have given different ...
Ernesto, Oqueli, Martin, Hiscock, Ronald, Dick   +2 more
openaire   +4 more sources

Aspirin and Clopidogrel Resistance

Hematology, 2007
AbstractAspirin and clopidogrel provide significant clinical benefit in patients with cardiovascular disease. However, given the complexity of platelet activation, it is not surprising that aspirin or clopidogrel prevent a small proportion of cardiovascular events.
Desmond J, Fitzgerald, Andrew, Maree
openaire   +2 more sources

Clopidogrel resistance: A diagnostic challenge

International Journal of Cardiology, 2009
No clear and generally accepted definition of clopidogrel resistance has been achieved up to now. We believe that the new point-of-care assays of platelet function may help the clinicians to overcome to define clopidogrel resistance especially in patients undergoing percutaneous coronary intervention in whom the level of inhibition of platelets is ...
Turgay, Celik, Atila, Iyisoy, Husamettin, Gul, Ersoy, Isik   +3 more
openaire   +2 more sources

Clopidogrel Resistance: Fact and Fiction

Future Cardiology, 2006
The antiplatelet agent clopidogrel in combination with aspirin has been shown to reduce thrombotic events in patients with acute coronary syndromes and/or who are undergoing percutaneous coronary intervention. However, a large interindividual response variability to clopidogrel has been described.
J W, van Werkum, A A C M, Heestermans, V H M, Deneer, C M, Hackeng, J M, Ten Berg   +4 more
openaire   +2 more sources

Clinical implications of clopidogrel resistance

Thrombosis and Haemostasis, 2008
SummaryThe benefits of clopidogrel in the treatment and prevention of coronary artery disease are well established, however, not all individuals respond in the same way to clopidogrel; there are patients who suffer adverse events despite clopidogrel treatment.
Antonio, De Miguel, Borja, Ibanez, Juan José, Badimón   +2 more
openaire   +2 more sources

The “Clopidogrel Resistance” Trap

The American Journal of Cardiology, 2007
a p w b e p “ S b s “ t a s i n i v t p m d e o n s u a b o b b S f d v r p e w a a ( r d p d Q v f t o w o Numerous randomized trials have indicated the benefits f clopidogrel either as an alternative1 or as an adjunct2 to spirin for the secondary prevention of acute vascular vents, including absolute mortality reduction in the largest ver acute ...
openaire   +2 more sources